Premium
Retrospective evaluation of biopsychosocial determinants and treatment response in patients receiving devil's claw extract (doloteffin R )
Author(s) -
Thanner J.,
Kohlmann Th.,
Künzel O.,
Chrubasik S.
Publication year - 2009
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2731
Subject(s) - biopsychosocial model , medicine , depression (economics) , retrospective cohort study , pain relief , claw , alternative medicine , postmarketing surveillance , physical therapy , psychiatry , anesthesia , adverse effect , pathology , economics , macroeconomics , mechanical engineering , engineering
In a retrospective evaluation of patients taking part for 2 months in a postmarketing surveillance study on the effectiveness and safety of Harpagophytum procumbens , associations were found to known explanators of pain, disability and depression. Therefore, treatment non‐responders might best be referred to a multimodal pain relief program that deals with fear avoidance beliefs, enhances experiences that decrease perceptions linking disability and pain and forces the patients to rethink the way they deal with the problem. However, during treatment with the aqueous Harpagophytum extract, this decision might reasonably be postponed to the end of month 4, since it has been shown that the maximum pain relief occurs after 3–4 months. Copyright © 2008 John Wiley & Sons, Ltd.